Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D6EQ3X
|
|||
| Drug Name |
MV-CHIK
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Chikungunya virus infection [ICD-11: 1D40; ICD-9: 001-139, 042-075] | Phase 2 | [1] | |
| Company |
Themis Bioscience
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02861586) Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine (MV-CHIK-202). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.